Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report

Posttransplant lymphoproliferative disorder (PTLD) is a rare complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) with poor prognosis. We report a patient with PTLD involved central nervous system (CNS) who treated with zanubrutinib, a second-generation Bruton tyrosine k...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ting-Ting, Chen, Wei-Hao, Zhao, Yan-Min, Fu, Hua-Rui, Huang, He, Shi, Ji-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117139/
https://www.ncbi.nlm.nih.gov/pubmed/33996600
http://dx.doi.org/10.3389/fonc.2021.672052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117139/
https://www.ncbi.nlm.nih.gov/pubmed/33996600
http://dx.doi.org/10.3389/fonc.2021.672052

Ejemplares similares